Drugs from ORYZON shown to be efficacious in the treatment of Acute Leukemia
Drugs against LSD1 discovered and developed by Oryzon, a Biopharmaceutical company dedicated to the discovery of biomarkers and development of novel therapeutics and diagnostics, have been shown to be effective in the treatment of acute leukemia’s. These preclinical findings are reported from two independent groups in UK in the last month issues of Nature Medicine and Cancer Cell. These promising results open new avenues to treat these cancers.
